1.48
price down icon3.90%   -0.06
after-market After Hours: 1.48
loading
60 Degrees Pharmaceuticals Inc stock is traded at $1.48, with a volume of 52,505. It is down -3.90% in the last 24 hours and up +4.96% over the past month. 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.54
Open:
$1.49
24h Volume:
52,505
Relative Volume:
0.10
Market Cap:
$6.07M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1484
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+6.47%
1M Performance:
+4.96%
6M Performance:
-19.57%
1Y Performance:
-76.32%
1-Day Range:
Value
$1.44
$1.54
1-Week Range:
Value
$1.34
$1.56
52-Week Range:
Value
$1.215
$12.45

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Name
60 Degrees Pharmaceuticals Inc
Name
Phone
202-327-5422
Name
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2025-08-15
Name
Latest SEC Filings
Name
SXTP's Discussions on Twitter

Compare SXTP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
1.48 6.32M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News

pulisher
Sep 30, 2025

Will 60 Degrees Pharmaceuticals Inc. rebound enough to break evenJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What does recent volatility data suggest for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Using Python tools to backtest 60 Degrees Pharmaceuticals Inc. strategiesTrade Entry Report & AI Enhanced Trading Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Real time breakdown of 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performanceJuly 2025 Opening Moves & Community Driven Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

How buybacks impact 60 Degrees Pharmaceuticals Inc. stock valueWeekly Market Report & Daily Technical Forecast Reports - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Sector ETF performance correlation with 60 Degrees Pharmaceuticals Inc.Weekly Trade Recap & Intraday High Probability Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why retail investors pile into 60 Degrees Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is now a turning point for 60 Degrees Pharmaceuticals Inc. Equity WarrantWeekly Trade Report & Safe Capital Growth Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What Fibonacci levels say about 60 Degrees Pharmaceuticals Inc. Equity Warrant reboundJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock gaining market shareWeekly Market Summary & Target Return Focused Stock Picks - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Using RSI to spot recovery in 60 Degrees Pharmaceuticals Inc.Quarterly Trade Review & Long-Term Safe Investment Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Analyzing recovery setups for 60 Degrees Pharmaceuticals Inc. investorsRate Cut & Fast Entry High Yield Tips - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Is this a good reentry point in 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Earnings Surprises & Community Consensus Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Analyzing Aurinia Pharmaceuticals (NASDAQ:AUPH) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World

Sep 30, 2025
pulisher
Sep 30, 2025

What candlestick patterns are forming on 60 Degrees Pharmaceuticals Inc.July 2025 Retail & Daily Chart Pattern Signals - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Tools to assess 60 Degrees Pharmaceuticals Inc. Equity Warrant’s risk profile2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What MACD and RSI say about 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

News impact scoring models applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantGold Moves & AI Enhanced Trading Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Risk adjusted return profile for 60 Degrees Pharmaceuticals Inc. analyzedJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Earnings visualization tools for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Volume spikes in 60 Degrees Pharmaceuticals Inc. stock – what they meanWeekly Profit Summary & Verified Entry Point Signals - newser.com

Sep 29, 2025

60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Cap:     |  Volume (24h):